NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

$3.85
+0.29 (+8.15%)
(As of 04/24/2024 ET)
Today's Range
$3.63
$3.89
50-Day Range
$2.30
$5.06
52-Week Range
$1.53
$5.93
Volume
3,428 shs
Average Volume
101,158 shs
Market Capitalization
$30.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NTRB stock logo

About Nutriband Stock (NASDAQ:NTRB)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRB Stock Price History

NTRB Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Gerald Goodman's Net Worth
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Nutriband CEO Publishes Letter to Shareholders
Nutriband Inc NTRB
See More Headlines
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/13/2021
Today
4/24/2024
Next Earnings (Estimated)
4/24/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NTRB
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,480,000.00
Net Margins
-252.90%
Pretax Margin
-252.90%

Debt

Sales & Book Value

Annual Sales
$2.08 million
Book Value
$1.09 per share

Miscellaneous

Free Float
4,453,000
Market Cap
$30.15 million
Optionable
Not Optionable
Beta
0.86
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Serguei Melnik (Age 50)
    Founder, President, Company Secretary & Executive Chairman of the Board
    Comp: $200k
  • Mr. Gareth Sheridan (Age 34)
    Founder, CEO & Director
    Comp: $200k
  • Mr. Gerald Goodman (Age 76)
    CFO & Chief Accounting Officer
    Comp: $160k
  • Dr. Alan Smith Ph.D. (Age 58)
    COO & President of 4P Therapeutics
    Comp: $179k
  • Mr. Patrick Ryan (Age 38)
    Chief Technical Officer
  • Dr. Jeffrey Patrick Pharm.D. (Age 54)
    Chief Scientific Officer
  • Mr. Tyler Overk (Age 40)
    President of Active Intelligence

NTRB Stock Analysis - Frequently Asked Questions

How have NTRB shares performed in 2024?

Nutriband's stock was trading at $2.32 at the start of the year. Since then, NTRB stock has increased by 65.9% and is now trading at $3.85.
View the best growth stocks for 2024 here
.

Are investors shorting Nutriband?

Nutriband saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 36,300 shares, an increase of 1,412.5% from the March 15th total of 2,400 shares. Based on an average trading volume of 41,900 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.0% of the company's stock are short sold.
View Nutriband's Short Interest
.

How were Nutriband's earnings last quarter?

Nutriband Inc. (NASDAQ:NTRB) issued its earnings results on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.11. The firm earned $0.28 million during the quarter, compared to analysts' expectations of $0.50 million. Nutriband had a negative trailing twelve-month return on equity of 73.13% and a negative net margin of 252.90%.

When did Nutriband's stock split?

Nutriband shares split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly issued shares were payable to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

How do I buy shares of Nutriband?

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners